 | Up a level |
Chakraborty, Surajit and Shekhar, Nishant and Singhal, Lipika and Rawat, Rajneesh Singh and Duseja, Ajay and Verma, Rahul K and Bansal, Kanika and Kour, Ivneet and Biswas, Sanjay and Rajni, Ekadashi and Sahu, Suneeta and Patil, Prabhu B and Gautam, Vikas (2024) Susceptibility of clinical isolates of novel pathogen Stenotrophomonas sepilia to novel benzoquinolizine fluoroquinolone levonadifloxacin. JAC Antimicrob. Resist., 6 (4). dlae130.
